Página 4 - Melhores Cancro do rim médicos - TOP-103 médicos

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Chefe do Departamento de Urologia do Rambam Medical Center, o Dr. Amiel é especialista em cirurgia de cancro renal.

• Oncocirurgião com especialização em neoplasias urológicas
• Liderar uma equipa dedicada a casos complexos de cancro renal
• Trabalhar num dos principais centros médicos de Israel

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

O Dr. Yutkin tem mais de 20 anos de experiência médica, exercendo no prestigiado Hadassah Medical Center, em Jerusalém.

• Graduado pela Faculdade de Medicina da Universidade Hebraica de Jerusalém
• Especialização no diagnóstico e tratamento de condições complexas
• Comunicação fluente em inglês, hebraico e russo
• Trabalho em um hospital acadêmico e de pesquisa de ponta

Chefe de Urologia no Samsung Medical Center – O Dr. Choi é especialista em cirurgia de cancro renal, com foco na precisão e nos resultados dos pacientes.

• Liderar um dos principais departamentos de urologia da Coreia
• Especializar-se em tratamentos cirúrgicos de cancro renal
• Trabalhar num centro médico líder com acreditação JCI

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

O Prof. Serkan Deveci lidera a urologia no Medical Park Göztepe e é Editor de Secção da UpToDate, um importante recurso médico. Ele traz uma vasta experiência tanto da Turquia quanto dos EUA.

• Professor de urologia com formação especializada nos Estados Unidos
• Investigador ativo com mais de 620 citações nas suas publicações científicas
• Membro da American Urology Association e da North American SMSNA
• Especialista no tratamento de condições urológicas complexas além do cancro

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Realizou inúmeras cirurgias de tumor renal com preservação do órgão – uma competência essencial para manter a função renal. É professor e lidera uma associação de urologia.

• Mais de 41 anos de experiência como urologista na Alemanha
• Foco específico em oncologia urológica, incluindo cancro renal
• Docência em urologia na Universidade Goethe em Frankfurt
• Autor de mais de 100 artigos científicos na área
• Distinguido com um doutoramento pela Universidade Kapodistrias de Atenas

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Especialista em técnicas avançadas de laser e laparoscopia para cirurgia de cancro renal no Dievo Surgery Center.

• Realizar nefrectomia radical e procedimentos de preservação renal
• Especialista em abordagens minimamente invasivas, incluindo nefrolitotripsia percutânea
• Especialista em cirurgias urológicas reconstrutivas complexas
• Fornecer segundas opiniões para casos difíceis

Especialista em uro-oncologia e cirurgia urológica laparoscópica assistida por robô no Liv Hospital Ulus.

• 23 anos de experiência em cirurgia geral e oncologia cirúrgica
• Especialista em técnicas minimamente invasivas para câncer renal
• Membro da Associação Europeia de Urologia e da Associação Americana de Urologia
• Publicação de 31 artigos de pesquisa internacionais sobre condições urológicas

O Dr. Topcu formou-se em centros oncológicos de excelência, incluindo o MD Anderson e o Sunnybrook Odette, especializando-se em cancro do rim entre outras condições oncológicas.

• Certificado em oncologia médica com vasta formação nos EUA e Canadá
• Membro de sociedades de prestígio como ESMO e ASCO
• Trabalhar no Hospital Universitário Biruni, uma instituição médica de referência
• Especializar-se numa vasta gama de cancros, incluindo tipos raros

Especializado em radioncologia na Universidade de Marmara – o Dr. Sahibov concentra-se em tratamentos precisos para o cancro do rim.

• Concluir uma formação de especialização rigorosa numa universidade turca de topo
• Trabalhar no departamento de radioncologia do Hospital Emsey
• Formar-se tanto no Azerbaijão como na Turquia